Russia's Sputnik V Vaccine 91.6% Effective In Late-Stage Trial: Lancet | Read
Russia's Sputnik V vaccine is 91.6 percent effective against symptomatic Covid-19, according to results published in The Lancet on Tuesday that independent experts said allayed transparency concerns over the jab, which Moscow is already rolling out.
